Importantly, the CD4+ T/CD8+ T cell ratio was significantly increased in calcipotriol- compared with EtOH-treated tumors, demonstrating that CD4+ T cells constituted the majority of tumor-infiltrating T cells in calcipotriol-treated PyMt mammary tumors (Figure 1, H–J). The gene discussed is CD8A; the disease is neoplasm.